In vivo, AAV9‐mediated FBXO2 delivery attenuated disc degeneration in rats by suppressing ferroptosis and restoring collagen II expression, whereas FBXO2 KO accelerated IVDD via LCN2‐dependent pathways. The gene discussed is LCN2; the disease is intervertebral disk degenerative disorder.